AEON Biopharma Edges Higher Stock Rises 275 as it Tests Key Resistance Nationwide Customer Challenges Board Election Process Citing Unfair Treatment GHC Q1 2026 Earnings EPS Surges Past Estimates Stock Slightly Down Mortgage Rate Outlook Key Signal from 10Year Treasury Yields